Sylum Pharmaceuticals Private Limited
About Sylum Pharmaceuticals Private Limited
Data last updated:
Sylum Pharmaceuticals Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U51909HP2017PTC006764. Its GSTIN is 02AAZCS3861K1ZR (Himachal Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Praveen Kumar (Whole-Time Director) and Pushapa Sharma.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Basement 1 Floor Old Dav School Building Rajgarh Road, Solan, Himachal Pradesh, India – 173212.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.38 Lakh, a growth of 85% compared to the previous year. For the same year it recorded a net profit of ₹1,935 (net margin 0.6%) and EBITDA of ₹28,195 (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sylum Pharmaceuticals Private Limited's registered office is in Solan, Himachal Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressBasement 1 Floor Old Dav School Building Rajgarh Road, Solan, Himachal Pradesh, India – 173212
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Sylum Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sylum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sylum Pharmaceuticals Private Limited, buy the company report.
Financials of Sylum Pharmaceuticals Private Limited
FY 2022 filings availableSylum Pharmaceuticals Private Limited reported revenue of ₹3.38 Lakh (up 85% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 85% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28,195 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,935 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sylum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sylum Pharmaceuticals Private Limited
Sylum Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar | Whole-Time Director | 24 Oct 2017 | 9 Years 0 Months | Current |
| Pushapa Sharma | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Sylum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sylum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sylum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAZCS3861K1ZR | Himachal Pradesh | Active | 02 Dec 2017 |
To see the full GST registrations and return filing status of Sylum Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sylum Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Deepak Kumar Verma ceased to be Director on 22 Jul 2019.
Frequently asked questions
Sylum Pharmaceuticals is an active private limited company based in Solan, Himachal Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 24 October 2017 (9+ years old) and is registered under CIN U51909HP2017PTC006764.
Sylum Pharmaceuticals has 2 current directors:
- Praveen Kumar - Whole-Time Director
- Pushapa Sharma - Director
The latest financial statements of Sylum Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sylum Pharmaceuticals is 02AAZCS3861K1ZR, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Sylum Pharmaceuticals is U51909HP2017PTC006764. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sylum Pharmaceuticals was incorporated on 24 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Deepak Kumar Verma ceased to be Director on 22 Jul 2019. Pushapa Sharma was appointed as Director on 08 Jul 2019. Praveen Kumar was appointed as Whole-Time Director on 24 Oct 2017.
The registered office of Sylum Pharmaceuticals is at Basement 1 Floor Old Dav School Building Rajgarh Road, Solan, Himachal Pradesh, India – 173212.
Sylum Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Sylum Pharmaceuticals is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
